Chen Long

-:(010)82266633 、 (2016、2021) (2010) 2022.02-, 、 、 2021.04-2022.01, - 1.,2024-2026,100,,; 2. “ +X”,2025-2027,10 /,,; 3.,132,,; 4.,2018-2020,660,,; 5.,424,,; 6. -,200,,; 7.,100, SCI 1. Chen L *, Shang C *, Wang Z *, Zheng M *, Zhang C, Li D, Yang Z, Dong Y, Xu Y, Yuan Y#, Fan S#, Zhong W#, Lin J#, Li X#. Chemical cross-linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual-antigen subunit vaccine. MedComm. 2025, 6(1):e70045. 2. Zuo K, Liu N, Zhou P, Zheng M, Wang L, Tang T, Yang Z, Chen L #, Zhu X#. Human serum albumin promotes interactions between HSA-IL-2 fusion protein and CD122 for enhancing immunotherapy. Biomed Pharmacother. 2024, 181:117664. 3. Zheng MZ, Yang ZQ, Cai SL, Zheng LT, Xue Y, Chen L #, Lin J#. Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis. Lung Cancer. 2024, 196:107957. 4. Zheng L, Li M, Li Y, Wu L, Naveena K, Zheng M, Yang Z, Pan Y, Zhang Y, Chen S, Qiao Y, Xu Y, Chen L #, Shi X#. Sestrin2 plays a protective role in age-related hearing loss by inhibiting NLRP3-inflammasome activity. Mech Ageing Dev. 2024, 221:111964. 5. Xiao H, Chen H, Zhang L, Duolikun M, Zhen B, Kuerban S, Li X, Wang Y, Chen L #, Lin J#. Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma. World J Surg Oncol. 2024, 22(1):152. 6. Chen L *, Ren A *, Zhao Y *, Chen H, Wu Q, Zheng M, Zhang Z, Zhang T, Zhong W, Lin J, Zhu H. Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL. J Hematol Oncol. 2023, 16(1):113. 7. Chen L *, Xu N *, Wang P *, Zhu H, Zhang Z, Yang Z, Zhang W, Guo H, Lin J. Nanoalbumin-prodrug conjugates prepared via a thiolation-and-conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8 + T-cell infiltration. Bioeng Transl Med. 2022, 8(1):e10377. 8. Shi X *, Wang Z *, Ren W *, Chen L *, et al. LDL receptor-related protein 1 (LRP1), a novel target for opening blood-labyrinth barrier (BLB). Signal Transduct Target Ther. 2022, 7(1):175. 9. Chen L *, Liu B*, Sun P, Wang W, Luo S, Zhang W, Yang Y, Wang Z, Lin J#, Chen PR#. Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Nanogel as a Pro-Antigen Strategy with Enhanced Protective Immune Responses. Small. 2020, 16(46):e2004237. 10. Xu N*, Yang YF*, Chen L #, Lin J#. A Ferritin-Albumin-Cu Nanoparticle that Efficaciously Delivers Copper(II) Ions to a Tumor and Improves the Therapeutic Efficacy of Disulfiram. ACS Omega. 2020, 5(18):10415-10422. 11. Ge Y*, Chen L *, Liu S, Zhao J, Zhang H, Chen PR#. Enzyme-Mediated Intercellular Proximity Labeling for Detecting Cell-Cell Interactions. J Am Chem Soc. 2019, 141(5):1833-1837. 12. Chen L *, Zeng D*, Xu N, Li C, Zhang W, Zhu X, Gao Y, Chen PR, Lin J#. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases. ACS Appl Mater Interfaces. 2019, 11(45):41889-41897. 2024,, 2023,MCE, -